pentobarbital will minimize the extent or outcome of linagliptin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Use of different treatment plans is strongly proposed when linagliptin is usually to be administered which has a CYP3A4 inducer
pentobarbital will lower the extent or effect of roflumilast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not recommended; powerful cytochrome P450 enzyme inducers lower systemic publicity to roflumilast and may lessen the therapeutic success
Contraindicated (1)pentobarbital will lower the extent or effect of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is accountable for the development and elimination of cariprazine's Lively metabolites.
pentobarbital will reduce the extent or outcome of imatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Mysterious.
pentobarbital will decrease the extent or outcome of irinotecan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will decrease the level or influence of elagolix by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will reduce the level or effect of pantoprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unfamiliar.
pentobarbital raises effects of ifosfamide by impacting hepatic enzyme CYP2B6 metabolism. Use Caution/Keep track of. Coadministration of ifosfamide with CYP2B6 inducers may boost metabolism of ifosfamide to its metabolite. Keep track of for elevated effects/toxicities if coupled with CYP2B6 inducers.
pentobarbital will lessen the level or result of cobimetinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Keep away from coadministration. Sturdy or moderate CYP3A inducers may possibly reduce cobimetinib systemic exposure by >eighty% and decrease its efficacy.
pentobarbital will decrease read more the extent or effect of trazodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will decrease the level or result of piroxicam by influencing hepatic enzyme CYP2C9/10 metabolism. Minimal/Importance Unidentified.
pentobarbital will lessen the level or effect of pioglitazone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
pentobarbital will minimize the extent or outcome of etonogestrel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will decrease the level or outcome of bortezomib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.